MedPath

HUNTER MEDICAL RESEARCH INSTITUTE

HUNTER MEDICAL RESEARCH INSTITUTE logo
🇦🇺Australia
Ownership
Private
Established
1998-01-01
Employees
1K
Market Cap
-
Website
https://hmri.org.au

ESTEEM After Stroke Program Launches Phase III Trial to Enhance Stroke Recovery

The ESTEEM After Stroke program, a Phase III trial funded by the Medical Research Future Fund, is testing a community-based approach combining exercise, socialization, and cognitive activities to improve recovery and quality of life for stroke survivors. This innovative program, led by researchers from Hunter New England Local Health District, HMRI, and the University of Newcastle, aims to validate the effectiveness of environmental enrichment in stroke rehabilitation.

NSW Pharmacy Trials Expand Access to Care for UTIs, Contraceptives, and Skin Conditions

• Pharmacy-led trials in NSW, Australia, have successfully expanded healthcare access for uncomplicated UTIs, allowing trained pharmacists to manage and treat the condition. • A trial resupplying oral contraceptives through pharmacies has shown positive feedback, leading to an expansion of patient age eligibility from 18-35 to 18-49 years. • Dermatology trials have commenced, enabling pharmacists to provide consultations and treatments for skin conditions like impetigo, herpes zoster, mild atopic dermatitis, and mild plaque psoriasis. • These trials aim to improve healthcare accessibility and inform policy decisions, emphasizing collaboration between pharmacists and general practitioners for optimized patient care.
© Copyright 2025. All Rights Reserved by MedPath